ABCL
AbCellera Biologics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ABCL fundamentals
AbCellera Biologics (ABCL) expects to report earnings on Aug 7, 2025, with estimated revenue of 7.55M (YoY +3.10%), and EPS at -0.16 (YoY -23.08%).
Revenue estimate / YoY
7.55M
+3.10%
EPS estimate / YoY
-0.16
-23.08%
Report date
Aug 7, 2025
Earnings Call
5:00 PM on Aug 7, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
ABCL has released its 2025 Q1 earnings report, with revenue of 4.24M, reflecting a YoY change of -57.45%, and net profit of -45.62M, showing a YoY change of -12.34%. The Sankey diagram below clearly presents ABCL's revenue sources and cost distribution.
Key Indicators
AbCellera Biologics (ABCL) key financial stats and ratios, covering profitability, financial health, and leverage.
AbCellera Biologics (ABCL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
AbCellera Biologics (ABCL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
AbCellera Biologics (ABCL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does AbCellera Biologics (ABCL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track AbCellera Biologics (ABCL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did AbCellera Biologics’s management provide for the next earnings period? How were AbCellera Biologics’s latest financial results overall?What is the market’s earnings forecast for AbCellera Biologics next quarter?What were the key takeaways from AbCellera Biologics’s earnings call?What is AbCellera Biologics’s gross profit margin?What does AbCellera Biologics do and what are its main business segments?What is AbCellera Biologics’s latest dividend and current dividend yield?Did AbCellera Biologics beat or miss consensus estimates last quarter?